Literature DB >> 30293111

Management of patients with stroke treated with direct oral anticoagulants.

D J Seiffge1,2, A A Polymeris1, J Fladt1, P A Lyrer1, S T Engelter1,3, Gian Marco De Marchis4.   

Abstract

Since their market approval, direct oral anticoagulants (DOACs) are being increasingly used for stroke prevention in patients with atrial fibrillation. However, the management of DOAC-treated patients with stroke poses several challenges for physicians in everyday clinical practice, both in the acute setting and in long-term care. This has spurred extensive research activity in the field over the past few years, which we review here.

Entities:  

Keywords:  Atrial fibrillation; DOAC; Stroke

Mesh：

Substances：

Year:  2018        PMID： 30293111     DOI： 10.1007/s00415-018-9061-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  91 in total

1.  Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Authors:  Graeme J Hankey; Manesh R Patel; Susanna R Stevens; Richard C Becker; Günter Breithardt; Antonio Carolei; Hans-Christoph Diener; Geoffrey A Donnan; Jonathan L Halperin; Kenneth W Mahaffey; Jean-Louis Mas; Ayrton Massaro; Bo Norrving; Christopher C Nessel; John F Paolini; Risto O Roine; Daniel E Singer; Lawrence Wong; Robert M Califf; Keith A A Fox; Werner Hacke
Journal:  Lancet Neurol       Date:  2012-03-07       Impact factor: 44.182

2.  Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.

Authors:  Chang Hyo Yoon; Yoon Kyung Park; Suk Jae Kim; Mi-ji Lee; Sookyung Ryoo; Gyeong-Moon Kim; Chin-Sang Chung; Kwang Ho Lee; June Soo Kim; Oh Young Bang
Journal:  Stroke       Date:  2014-08-21       Impact factor: 7.914

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Eur J Cardiothorac Surg       Date:  2016-09-23       Impact factor: 4.191

4.  Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.

Authors:  Tze-Fan Chao; Chia-Jen Liu; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Jo-Nan Liao; Fa-Po Chung; Tzeng-Ji Chen; Gregory Y H Lip; Shih-Ann Chen
Journal:  Circulation       Date:  2018-02-28       Impact factor: 29.690

5.  Meta-analysis of safety and efficacy for direct oral anticoagulation treatment of non-valvular atrial fibrillation in relation to renal function.

Authors:  Rongjun Zou; Jun Tao; Wanting Shi; Minglei Yang; Hongmu Li; Xifeng Lin; Songran Yang; Ping Hua
Journal:  Thromb Res       Date:  2017-10-26       Impact factor: 3.944

Review 6.  Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Authors:  T Steiner; M Böhm; M Dichgans; H-C Diener; C Ell; M Endres; C Epple; M Grond; U Laufs; G Nickenig; H Riess; J Röther; P D Schellinger; M Spannagl; R Veltkamp
Journal:  Clin Res Cardiol       Date:  2013-05-14       Impact factor: 5.460

7.  Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.

Authors:  Laura C Gioia; Mahesh Kate; Leka Sivakumar; Dulara Hussain; Hayrapet Kalashyan; Brian Buck; Miguel Bussiere; Thomas Jeerakathil; Ashfaq Shuaib; Derek Emery; Ken Butcher
Journal:  Stroke       Date:  2016-05-24       Impact factor: 7.914

8.  Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Authors:  J Donald Easton; Renato D Lopes; M Cecilia Bahit; Daniel M Wojdyla; Christopher B Granger; Lars Wallentin; Marco Alings; Shinya Goto; Basil S Lewis; Mårten Rosenqvist; Michael Hanna; Puneet Mohan; John H Alexander; Hans-Christoph Diener
Journal:  Lancet Neurol       Date:  2012-05-08       Impact factor: 44.182

9.  Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation).

Authors:  Giuseppe Patti; Markus Lucerna; Ladislav Pecen; Jolanta M Siller-Matula; Ilaria Cavallari; Paulus Kirchhof; Raffaele De Caterina
Journal:  J Am Heart Assoc       Date:  2017-07-23       Impact factor: 5.501

10.  Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.

Authors:  Eri Toda Kato; Robert P Giugliano; Christian T Ruff; Yukihiro Koretsune; Takeshi Yamashita; Robert Gabor Kiss; Francesco Nordio; Sabina A Murphy; Tetsuya Kimura; James Jin; Hans Lanz; Michele Mercuri; Eugene Braunwald; Elliott M Antman
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501
View more
  4 in total

1.  Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.

Authors:  Thomas Raphael Meinel; Sebastién Frey; Marcel Arnold; Sarah Kendroud; Urs Fischer; Johannes Kaesmacher; Mirjam Rachel Heldner; Simon Jung
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

2.  Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.

Authors:  David J Seiffge; Maurizio Paciaroni; Duncan Wilson; Masatoshi Koga; Kosmas Macha; Manuel Cappellari; Sabine Schaedelin; Clare Shakeshaft; Masahito Takagi; Georgios Tsivgoulis; Bruno Bonetti; Bernd Kallmünzer; Shoji Arihiro; Andrea Alberti; Alexandros A Polymeris; Gareth Ambler; Sohei Yoshimura; Michele Venti; Leo H Bonati; Keith W Muir; Hiroshi Yamagami; Sebastian Thilemann; Riccardo Altavilla; Nils Peters; Manabu Inoue; Tobias Bobinger; Giancarlo Agnelli; Martin M Brown; Shoichiro Sato; Monica Acciarresi; Hans Rolf Jager; Paolo Bovi; Stefan Schwab; Philippe Lyrer; Valeria Caso; Kazunori Toyoda; David J Werring; Stefan T Engelter; Gian Marco De Marchis
Journal:  Ann Neurol       Date:  2019-04-30       Impact factor: 10.422

3.  Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation.

Authors:  Alexandros A Polymeris; Kosmas Macha; Maurizio Paciaroni; Duncan Wilson; Masatoshi Koga; Manuel Cappellari; Sabine Schaedelin; Annaelle Zietz; Nils Peters; David J Seiffge; David Haupenthal; Luise Gassmann; Gian Marco De Marchis; Ruihao Wang; Henrik Gensicke; Svenja Stoll; Sebastian Thilemann; Nikolaos S Avramiotis; Bruno Bonetti; Georgios Tsivgoulis; Gareth Ambler; Andrea Alberti; Sohei Yoshimura; Martin M Brown; Masayuki Shiozawa; Gregory Y H Lip; Michele Venti; Monica Acciarresi; Kanta Tanaka; Maria Giulia Mosconi; Masahito Takagi; Rolf H Jäger; Keith Muir; Manabu Inoue; Stefan Schwab; Leo H Bonati; Philippe A Lyrer; Kazunori Toyoda; Valeria Caso; David J Werring; Bernd Kallmünzer; Stefan T Engelter
Journal:  Ann Neurol       Date:  2021-11-29       Impact factor: 11.274

4.  Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.

Authors:  Thomas R Meinel; Mattia Branca; Gian Marco De Marchis; Krassen Nedeltchev; Timo Kahles; Leo Bonati; Marcel Arnold; Mirjam R Heldner; Simon Jung; Emmanuel Carrera; Elisabeth Dirren; Patrik Michel; Davide Strambo; Carlo W Cereda; Giovanni Bianco; Georg Kägi; Jochen Vehoff; Mira Katan; Manuel Bolognese; Roland Backhaus; Stephan Salmen; Sylvan Albert; Friedrich Medlin; Christian Berger; Ludwig Schelosky; Susanne Renaud; Julien Niederhauser; Christophe Bonvin; Michael Schaerer; Marie-Luise Mono; Biljana Rodic; Alexander A Tarnutzer; Pasquale Mordasini; Jan Gralla; Johannes Kaesmacher; Stefan Engelter; Urs Fischer; David J Seiffge
Journal:  Ann Neurol       Date:  2020-10-17       Impact factor: 10.422
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.